Fig. 1: Screening, randomization, and follow-up of the patients. | Nature Communications

Fig. 1: Screening, randomization, and follow-up of the patients.

From: Edaravone dexborneol for ischemic stroke with sufficient recanalization after thrombectomy: a randomized phase II trial

Fig. 1

aAfter randomization, 101 patients assigned into ED group and 103 patients assigned into Control group. In ED group, 4 patients were excluded due to decline to participate (n = 1) and error enrollment after randomization (n = 3). bIncluded giving up treatment due to clinical deterioration (n = 6) and economic reasons (n = 6), and transferring to other hospitals (n = 3). cincluded giving up treatment due to clinical deterioration (n = 8) and economic reasons (n = 7), and transferring to other hospitals (n = 8).

Back to article page